May 18, 2026 04:46PM

Apr 30, 2026 06:22AM

Apr 30, 2026 06:00AM

Feb 5, 2026 07:24AM

Nov 20, 2025 07:45AM

Nov 17, 2025 06:26AM

Aug 4, 2025 04:33PM OS Therapies (OSTX) Files for 3.76M Share Offering by Selling Stockholders

Jul 3, 2025 07:41AM

Jun 30, 2025 06:02AM

Jun 24, 2025 07:41AM

Jun 10, 2025 07:40AM

Jun 6, 2025 07:31AM

May 16, 2025 04:34PM

May 7, 2025 08:45AM OS Therapies (OSTX) Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Imm

Apr 22, 2025 07:41AM

Apr 22, 2025 07:34AM

Apr 9, 2025 07:40AM

Mar 31, 2025 07:40AM

Feb 24, 2025 07:25AM

Feb 20, 2025 05:54AM

Feb 14, 2025 07:36AM OS Therapies (OSTX) Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing

Feb 4, 2025 07:33AM

Jan 15, 2025 07:45AM

Dec 31, 2024 03:38PM

Dec 26, 2024 10:03AM

Dec 24, 2024 09:32AM

Oct 28, 2024 04:44PM

Sep 13, 2024 08:09AM OS Therapies (OSTX) Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates

Sep 3, 2024 07:17AM

Aug 29, 2024 07:53AM

Aug 22, 2024 01:01PM

Aug 2, 2024 08:56AM

Jul 24, 2024 10:50AM

416,944 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All